Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab Step-Down Maintenance Therapy in Severe Asthma (TAPER)
NCT07363642Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Jan 2026
- Primary completion
- Feb 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of tezepelumab in severe asthma, sponsored by AstraZeneca. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
severe asthma
Beyond the preview
Go deeper on NCT07363642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363642.